CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MetaTox-HS project aims to develop affordable and accessible in vitro tests for cell metabolism and toxicity using fluorescence nanosensor technology. This innovation allows researchers in various laboratories to perform high-performance tests without needing expensive equipment, ultimately enhancing drug developme…
Drug failure and high development cost (est. €2.3bn/new drug) has driven enormous growth in market need for scientific tests and models of disease, for researchers in academia, institutions and the pharmaceutical industry, that better translate from the bench (in vitro) to the bedside (in vivo).
Critical tests are either not available, or only available on a few large, expensive dedicated instruments.
Luxcel Biosciences Ltd (LUX) has prototyped innovation that can now bring these high performanc…
LUXCEL BIOSCIENCES LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
